MMCapS XVII Final Offering Circular - Irish Stock Exchange
MMCapS XVII Final Offering Circular - Irish Stock Exchange
MMCapS XVII Final Offering Circular - Irish Stock Exchange
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
There are no terms in the Insurance Surplus Note that limit the ability of the Insurance Surplus Note Issuer<br />
to incur additional indebtedness, secured or unsecured, including any Senior Indebtedness, or to be subject to Senior<br />
Claims. Additionally, no such terms limit the Insurance Surplus Note Issuer from issuing any future surplus notes or<br />
any other similar obligations. Unless expressly subordinated to the Insurance Surplus Note, any future surplus notes<br />
or other similar obligations issued by the Insurance Surplus Note Issuer would rank pari passu or senior in right of<br />
payment to the Insurance Surplus Note issued by the Insurance Surplus Note Issuer. See “Security for the Notes—<br />
Description of the Insurance Surplus Note— Subordination.”<br />
The regulation and authority for the issuance of the Insurance Surplus Note are governed by the laws of the<br />
state having jurisdiction over the Insurance Surplus Note Issuer, which authorize the issuance of surplus notes and<br />
address their accounting treatment and repayment terms. In addition, the Applicable Regulator will generally<br />
require that the terms of the Insurance Surplus Note are consistent with SAP accounting guidelines, which provide<br />
for accounting treatment of surplus notes. Consistent with SAP guidelines relating to surplus notes, the Insurance<br />
Surplus Note can only be issued pursuant to the approval of the Applicable Regulator. Further, each payment of<br />
principal of or premium, if any, and interest on the Insurance Surplus Note is subject to the approval of the<br />
Applicable Regulator, which approval may be subject to a determination by the Applicable Regulator that the<br />
financial condition of the Insurance Surplus Note Issuer warrants the making of such payments. The Applicable<br />
Regulator will have broad discretion in determining whether to allow payments to be made on the Insurance Surplus<br />
Note. Accordingly, because the ability of the Insurance Surplus Note Issuer to redeem or make scheduled or other<br />
payments on its Insurance Surplus Note is subject to the Applicable Regulator’s prior approval, there can be no<br />
assurance as to whether and when any such payments will be made, and if made, the amount of any such payments.<br />
The order of the Applicable Regulator approving the issuance of the Insurance Surplus Note also provides a<br />
cap on the rate or amount of interest that the Insurance Surplus Note Issuer may pay under its Insurance Surplus<br />
Note (“Regulatory Interest Rate Limitation”). Specifically, the Insurance Surplus Note Issuer, which represents<br />
2.7% of the aggregate Principal Balance of the Collateral Debt Securities, is subject to an interest rate cap equal to<br />
12.5% per annum. In addition, payments of principal of and premium, if any, and interest on the Insurance Surplus<br />
Note may only be made from the funds and other assets of the Insurance Surplus Note Issuer legally available to<br />
make payments with respect to the Insurance Surplus Note under Applicable Insurance Laws. Furthermore, the<br />
funds available to make payments on the Insurance Surplus Note on any given date, whether with respect to<br />
principal, premium, if any, or interest, will be determined by the Applicable Regulator and may be limited by<br />
various factors, such as requirements under a given state’s insurance laws affecting the relative level of surplus (e.g.,<br />
minimum surplus requirements and risk based capital standards specifying minimum capital levels). For the<br />
purposes of determining compliance with such surplus adequacy requirements, the surplus of an insurance company<br />
is determined on the basis of SAP rather than GAAP, which is generally a more conservative measure of an<br />
insurance company’s surplus.<br />
The approval of the issuance of the Insurance Surplus Note by an Applicable Regulator does not constitute<br />
a guarantee or recommendation of the Insurance Surplus Note by the Applicable Regulator or approval of any<br />
payments to be made in respect of the Insurance Surplus Note.<br />
Any failure by the Insurance Surplus Note Issuer to (i) make a payment of principal of or premium, if any,<br />
or interest on its Insurance Surplus Note due to a disapproval of such payment by the Applicable Regulator or<br />
(ii) pay the portion of any interest payment that would exceed a Regulatory Interest Rate Limitation, as applicable,<br />
will not constitute a default under the Insurance Surplus Note. However, the Insurance Surplus Note will be deemed<br />
to be a Defaulted Security under the Indenture if any payment of principal or premium, if any, or interest by the<br />
Insurance Surplus Note Issuer is not made when scheduled as a result of any Payment Restrictions, even though the<br />
failure to make any such payment is permitted by the terms of the Insurance Surplus Note Indenture.<br />
Prospective purchasers of the Notes should consider and assess for themselves the likely level of defaults,<br />
the likely level and timing of recoveries on the Insurance Surplus Note in the Trust Estate, and the likely levels of<br />
interest rates during the term of the Notes.<br />
Certain criteria relating to the Insurance Surplus Note Issuer were required to be met as of the date of the<br />
acquisition by the Issuer. However, the Insurance Surplus Note Issuer is under no obligation to maintain such<br />
criteria after such date and none of the Insurance Surplus Note Issuer, the Initial Purchasers, the Placement Agents<br />
24